Intra Cellular Therapies reported $4.48B in Market Capitalization this October of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.28B 1.63B
ALKERMES ALKS:US 4.89B 0.63B
Aptinyx Inc APTX:US $ 0.04B 0.12B
Biocryst Pharmaceuticals BCRX:US $ 1.97B 1.04B
Biogen BIIB:US $ 29.87B 1.08B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Cytokinetics CYTK:US $ 3.36B 0.22B
Esperion Therapeutics ESPR:US $ 0.4B 0.11B
Gilead Sciences GILD:US $ 77.53B 2.87B
Halozyme Therapeutics HALO:US $ 6.07B 0.58B
Intra Cellular Therapies ITCI:US $ 5.38B 0.37B
JAZZ PHA JAZZ:US 9.74B 0.13B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Marinus Pharmaceuticals MRNS:US $ 0.18B 0.17B
Minerva Neurosciences NERV:US $ 0.02B 0.02B
Nektar Therapeutics NKTR:US $ 0.71B 0.3B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Novartis NVS:US 203.52B 10.87B
Prothena PRTA:US 1.27B 0.44B
Redhill Biopharma RDHL:US 0.13B 0B
Supernus Pharmaceuticals SUPN:US $ 1.54B 0.18B
United Therapeutics UTHR:US $ 10.67B 2.55B
Vanda Pharmaceuticals VNDA:US $ 0.62B 0.02B